Results 11 to 20 of about 4,217 (179)
Acta Médica Portuguesa, 1993 Four cases of pregnancy in patients with Myasthenia Gravis are presented. No significant pregnancy complications occurred; labour/delivery and puerperium did not present many differences from those expected in healthy women.
A Colaço, C G Cardoso, L M Graça
doaj +2 more sources
Miastenia gravis diagnostic in dogs
Revista de Medicina Veterinaria, 2010 Miastenia Gravis is a neuromuscular disease caused by auto antibodies. Early Clinical and biochemical diagnosis and treatment is demanded in the assurementof quality and time of life in all dogs.
Adriana Patricia Suraniti +5 more
doaj +2 more sources
Síndrome de Dropped Head: Apresentação Rara de Miastenia Gravis
Gazeta Médica, 2023 A miastenia gravis é uma doença autoimune da junção neuromuscular que se caracteriza por fraqueza muscular e fadiga. A síndrome de dropped head é uma complicação rara da miastenia gravis e manifesta-se pela queda cefálica decorrente da fraqueza ...
João Mendes Sobral +4 more
doaj +4 more sources
Terapi plasma exchange pada krisis miastenik
JKS (Jurnal Kedokteran Syiah Kuala), 2022 Krisis miastenik adalah perburukan gejala yang terjadi pada pasien miastenia gravis, ditandai dengan kondisi gagal nafas. Sebanyak 15-20 % pasien miastenia gravis mengalami krisis miastenik dalam kehidupannya. Mortalitas akibat krisis miastenik pada saat
Yulia Trisna +2 more
doaj +1 more source
Jurnal Anestesi Perioperatif, 2020 Krisis miastenia adalah eksaserbasi akut miastenia gravis dengan kelemahan yang melibatkan otot-otot pernapasan sehingga terjadi kegagalan napas akut dan memerlukan dukungan ventilasi mekanik.
Titik Setyawati +2 more
doaj +1 more source
Perbandingan Plasmaferesis dan Imunoglobulin untuk Terapi Miastenia Gravis Juvenil
Sari Pediatri, 2020 Latar belakang. Manfaat imunomodulasi dengan plasmaferesis dan / atau imunoglobulin telah dibuktikan dalam beberapa penelitian tetapi efektivitas komparatifnya sebagai terapi, terutama pada miastenia gravis juvenil, belum diteliti secara luas.
Irawan Mangunatmadja +2 more
doaj +1 more source
MYH2 myopathy, a new case expands the clinical and pathological spectrum of the recessive form
Molecular Genetics &Genomic Medicine, Volume 8, Issue 9, September 2020., 2020 MYH2 mutations are responsible for a late‐onset autosomal dominant (AD) disease characterized by reduction in type 2A muscle fibre number and size along with rimmed vacuoles, and for an early‐onset recessive form characterized by complete loss of type 2A fibres.
Roberta Telese +12 more
wiley +1 more source
PATOFISIOLOGI MIASTENIA GRAVIS
JPHV (Journal of Pain, Vertigo and Headache), 2023 Myasthenia Gravis (MG) is an autoimmune disease that disrupts transmission at the neuromuscular junction (NMJ). In myasthenia gravis, the immune system will attack the acetylcholine receptor (AChR) or other proteins involved in neuromuscular transmission or due to abnormalities in the thymus, which plays a role in immunity.
Devita Anggraeni Soeroso +1 more
openaire +1 more source
Miastenia Gravis: diagnóstico y tratamiento
Archivo Médico de Camagüey, 2009 En este trabajo se pretende actualizar el tema de la Miastenia Gravis enfatizando en el diagnóstico y manejo tanto en la comunidad como en las salas de terapia intensiva.
Orestes Herrera Lorenzo +3 more
doaj +1 more source
Ruolo delle heat shock proteins nella patogenesi della miastenia gravis [PDF]
, 2010 Myasthenia Gravis (MG) is an autoimmune disorder of the neuromuscolar junction mediated by specific antibodies to the nicotinic acetylcholine receptors. Several clinical and experimental studies have confirmed that the HSPs are involved in the process of
MARINO GAMMAZZA, Antonella, ZUMMO, Leila
core +1 more source